Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- Bethesda, Maryland
- Most recent report
- 8-K, filed Oct 1, 2026
- Incorporated
- Delaware
- Filings on record
- 237 filings
- On EDGAR
- CIK 1819411
- Fiscal year ends
- December
- Filer status
- Emerging growth company
Financials 8 of 23
News 8 of 66
Prospectuses and Registrations 8 of 24
- S-8 Registration statement for an employee plan Dec 3, 2025
- 424B5 Prospectus supplement for an offering Nov 28, 2025
- S-3/A Shelf registration statement, amended Nov 7, 2025
- 424B5 Prospectus supplement for an offering Jul 17, 2025
- 424B5 Prospectus supplement for an offering Jul 15, 2025
- S-3 Shelf registration statement May 28, 2025
- S-8 Registration statement for an employee plan Sep 19, 2024
- 424B5 Prospectus supplement for an offering Sep 6, 2024
Proxies 8 of 10
- DEFA14A Extra proxy material Apr 28, 2026
- DEF 14A Proxy statement for a shareholder vote Apr 28, 2026
- DEFA14A Extra proxy material Apr 29, 2025
- DEF 14A Proxy statement for a shareholder vote Apr 29, 2025
- PRE 14A Preliminary proxy statement Apr 17, 2025
- DEFA14A Extra proxy material Apr 26, 2024
- DEF 14A Proxy statement for a shareholder vote Apr 26, 2024
- DEFA14A Extra proxy material Apr 28, 2023
Ownership 8 of 81
- 4 Insider reported a trade Jul 17, 2026
- 4 Insider reported a trade Jul 17, 2026
- 4 Insider reported a trade Jul 17, 2026
- 4 Insider reported a trade Jul 17, 2026
- 4 Insider reported a trade Jul 17, 2026
- 4 Insider reported a trade Jul 17, 2026
- 4 Insider reported a trade Mar 26, 2026
- 4 Insider reported a trade Mar 26, 2026
Other 8 of 33
- ARS Annual report sent to shareholders Apr 28, 2026
- UPLOAD Comment letter from SEC staff Jun 4, 2025
- ARS Annual report sent to shareholders Apr 29, 2025
- ARS Annual report sent to shareholders Apr 26, 2024
- EFFECT Notice that a registration became effective Dec 29, 2023
- CORRESP Reply to SEC staff Dec 22, 2023
- UPLOAD Comment letter from SEC staff Dec 21, 2023
- ARS Annual report sent to shareholders Apr 28, 2023
Everything here comes from Gain Therapeutics, Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.